GENE ONLINE|News &
Opinion
Blog

Biomarin Pharmaceuticals
Will Breakthrough Therapy Lead the Way? An Overview of the Approved Gene and Cell Therapies for 2022
2023-01-13
FDA Accepts Resubmission of BioMarin’s Gene Therapy Two Years After Rejection
2022-10-13
Homology Medicines Joins Biomarin in Gene Therapy Clinical Hold
2022-02-22
ARM 2022: Industry Briefs on Cell and Gene Therapies
2022-01-17
BioMarin’s Dwarfism Drug Garners FDA Nod Amidst Concerns Over Threat to Dwarf Pride
2021-11-21
The Transformative Potential of Gene Therapies for Hemophilia
2021-04-08
R&D
BioMarin Collaborates with Canadian Biotech for AI-based Drug Discovery
2020-11-22
FDA Rejects BioMarin Pharmaceuticals’ Valoctocogene Roxaparvovec Gene Therapy for Severe Hemophilia A
2020-08-20
LATEST
Previewing AACR 2024 With Select Pre-Meeting Highlights
2024-03-28
Roche Delivering on Malaria Screening Solutions for Blood Donation
2024-03-28
Innovating Cancer Treatment: The Role of ADC Technology at Nona Biosciences
2024-03-28
BIO CHINA 2024 Brings Biotech Experts and Industry Elites Together for Innovation
2024-03-27
Galderma’s Strong European IPO Debut
2024-03-26
Markets and Mergers: Boston Scientific and Axonics Shake Hands on Deal
2024-03-25
Discover the Next Billion-Dollar Unicorn at the Biotech Innovation Funding Networking Event
2024-03-21
EVENT
2024-04-06
Biotech Innovation Funding Networking
Los Angeles, USA
Scroll to Top